Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 515.26 million compared to CNY 561.69 million a year ago. Revenue was CNY 515.26 million compared to CNY 561.69 million a year ago.

Net income was CNY 44.78 million compared to CNY 72.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.1072 compared to CNY 0.1816 a year ago. Diluted earnings per share from continuing operations was CNY 0.1072 compared to CNY 0.1816 a year ago.